抗血小板药物患者颅内出血后输注血小板的作用:系统评价与Meta分析
该系统评价与Meta分析纳入16项临床试验,比较使用抗血小板药物的成人创伤性脑损伤或自发性颅内出血患者是否接受血小板输注,评估死亡、严重残疾和血肿扩大的差异。仅血肿扩大显示显著差异,风险差为-0.10(10%;95%CI -0.14至-0.05;P<0.0001;I²=0.90),支持血小板输注。按出血机制亚组分析结果相同。作者认为血小板输注对评估结局无明显获益,似乎轻微增加血栓栓塞性不良事件风险,但未达显著。
要点
- 仅血肿扩大显示显著差异,风险差-0.10(10%;95%CI -0.14至-0.05;P<0.0001;I²=0.90),支持血小板输注。
- 按出血机制亚组分析结果相同。
- 作者认为血小板输注对评估结局无明显获益,似乎轻微增加血栓栓塞性不良事件风险,但未达显著。
核心结论
- 作者认为使用抗血小板药物的颅内出血患者输注血小板对评估结局无明显获益,似乎轻微增加血栓栓塞性不良事件风险,但未达显著。
研究设计与样本
- 系统评价与Meta分析,检索随机或队列研究,比较使用抗血小板药物的成人创伤性脑损伤或自发性颅内出血患者接受或不接受血小板治疗。
- 共纳入16项临床试验,计算标准化风险差及95%置信区间,采用随机效应模型分析数据,通过I²统计量评估异质性。
主要发现
- 仅血肿扩大显示两组间显著差异:风险差为-0.10(10%;95%CI -0.14至-0.05;P<0.0001;I²=0.90),支持血小板输注。
- 按出血机制类型进行亚组分析,观察到相同结果。
- 使用抗血小板药物的颅内出血患者输注血小板似乎对评估结局无明显获益,似乎轻微增加血栓栓塞性不良事件风险,但未达显著。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The evidence suggests that antiplatelet agents (APA) slightly increase the risk of death and disease progression in patients with traumatic brain injury or spontaneous intracranial hemorrhage (ICH). There is little evidence that APA reversal with platelet (PLT) transfusion may improve the outcome. In this systematic review and meta-analysis, our goal was to evaluate the differences in mortality, severe disability, and hematoma expansion related to PLT transfusion. We retrieved randomized or cohort studies comparing adult patients on APA with traumatic brain injury or ICH who were treated with PLT or not. We calculated the standardized risk difference and 95% confidence interval. A random-effects model was applied to analyze the data. The heterogeneity of the retrieved trials was evaluated through the I2 statistic. Our review included 16 clinical trials. We observed a significant difference between the 2 groups only for hematoma expansion: risk difference was -0.10 (10%; 95% confidence interval, -0.14 to -0.05; P < 0.0001; I2 = 0.90) in favor of PLT transfusion. Performing subgroups analyses according to the type of bleeding mechanism, we observed the same results. The use of PLT in patients on APA affected by ICH seemed to have no clear beneficial effect for the outcomes evaluated; conversely, PLT seemed to slightly increase the odds for adverse events of thromboembolic origin, even although not significantly.
引用
- Brogi E, Corbella D, Coccolini F, et al. The Role of Platelet Transfusions After Intracranial Hemorrhage in Patients on Antiplatelet Agents: A Systematic Review and Meta-Analysis. World Neurosurg. 2020. PMID: 32289507. doi:10.1016/j.wneu.2020.03.216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。